The Covid-19 pandemic exposed the weaknesses in global pharmaceutical supply chains when it caused governments to shut their borders and manufacturing plants to close. Existing problems such as shortages of generic drugs and logistical and regulatory challenges hindered the ability of many organizations to quickly recover from disruptions.
As a result, many pharma companies realized the need to reinforce their supply chains using new technologies. This Pharma Logistics IQ report, produced in association with Controlant, looks at the technologies being implemented by pharmaceutical suppliers, how these are futureproofing supply chains and boosting their resilience.
Download this report to find out:
- How the pandemic impacted supply chains globally, exacerbating existing difficulties
- The value of real-time monitoring tools
- How digital transformation leads to more resilient supply chains